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Abstract
Background: Surgical interventions for symptomatic gallstone disease could be dangerous in patients with severe
comorbid conditions including liver cirrhosis. Here, we report our experience of living donor liver transplantation
(LDLT) indicated for two patients with liver cirrhosis complicated with gallstone diseases.
Case 1: A 70-year-old woman with a history of hepatitis C virus infection was diagnosed as symptomatic
choledocholithiasis. She had open cholecystectomy and choledochotomy with choledocholithotomy, which
complicated with postoperative liver failure. Her Child-Pugh score increased from 7 to 12 points and Model for
End-Stage Liver Disease (MELD) score from 11 to 36. She underwent LDLT, using the right lobe graft donated
by her 47-year-old daughter. The post-transplant graft function was excellent, and the patient was discharged
from the hospital on postoperative day 27.
Case 2: A 46-year-old man with a history of hepatitis B virus infection was diagnosed as cholecystitis. He had
cholecystostomy without any complications and his Child-Pugh score remained to be 9 and MELD score 17,
followed by LDLT using the right lobe graft donated by his 45-year-old wife. The post-transplant graft function
was excellent, and the patient was discharged from the hospital on postoperative day 44.
Conclusion: LDLT is one of treatment options when patients with Child-Pugh B cirrhosis accompanied with
gallstone diseases, likely to be deteriorating their liver functions in the near future.
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Background
Gallstones are common and detected as high as 4.11 %
in general population [1], and the rate would be 1.2 to
3 times higher in patients with chronic liver disease
(CLD) [2, 3]. Acute cholecystitis and cholangitis results
from obstruction of the cystic duct or common bile
duct, respectively, usually by gallstones, followed by in-
flammation of the gallbladder, or bile duct. Laparoscopic
cholecystectomy (LC) is the standard treatment for acute
cholecystitis in general population [4]. Cholangitis, on the
other hand, requires biliary decompression by endoscopic
or percutaneous transhepatic approaches and antibiotic
therapy [5]. Patients with symptoms caused by gallstone
(GS) disease can be difficult to manage if they have severe
comorbid conditions, including end-stage liver disease [6].
Morbidity and mortality after cholecystectomy get greater
in accords with Child-Pugh class [2], and Machado re-
ported that mortality after cholecystectomy of patients
with Child-Pugh A, B, and C liver cirrhosis was 0.12, 0.97,
and 17.1 %, respectively [7].
Because a poor outcome was observed, some study
recommends that percutaneous gall bladder aspiration
[8, 9] and endoscopic gallbladder stent placement [2, 10]
rather than operation may be a potential treatment or
temporizing measure for symptomatic gallbladder disease
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in patients with liver cirrhosis awaiting liver transplant-
ation (LT) [9, 11]. It is difficult, however, to await LT
with temporizing measure in Japan, considering the
severe shortage of cadaveric donor grafts [12]. Here, we
report our experience of living donor liver transplant-
ation (LDLT) for two patients with liver cirrhosis com-
plicated with GS diseases.
Case presentation
Case 1
A 70-year-old woman with hepatitis C virus (HCV) in-
fection and liver cirrhosis without any treatment came
to the primary hospital complaining of abdominal pain,
which was diagnosed as symptomatic choledocholithia-
sis. Her hepatic and renal profiles on admission were as
follows: total bilirubin, 1.6 mg/dl; albumin, 2.9 g/dl;
aspartate aminotransferase (AST), 45 U/l; international
normalized ratio (INR), 1.26; and creatinine, 0.69 mg/dl.
Endoscopic drainage was indicated, which failed unfor-
tunately because of esophageal varices. She did not
show any improvement with 22-day conservative treat-
ment, so she was scheduled for open cholecystectomy
and choledochotomy with choledocholithotomy as a
radical treatment. The operation itself was undergone
without trouble with operation time of 200 min and
blood loss of 316 ml. She was complicated with postop-
erative liver failure, however, with grade 1 encephalop-
athy and hyperbilirubinemia as high as total bilirubin
22.1 mg/dl on the postoperative day 12. So she was re-
ferred to our hospital on the postoperative day 32 for
possible LDLT after several plasma exchange did not
show any improvement. At the time of referral, her
hepatic and renal profiles were as follows: total biliru-
bin, 26.4 mg/dl; albumin, 2.9 g/dl; aspartate amino-
transferase (AST), 65 U/l; international normalized
ratio (INR), 1.42; and creatinine, 0.81 mg/dl. Abdominal
computed tomography (CT) imaging studies showed
massive ascites after the first operation (Fig. 1). Her
Child-Pugh score increased from 7 (grade B) to 12
points (grade C) and Model for End-Stage Liver Disease
(MELD) score from 11 to 36. LT was indicated for her
liver failure and she underwent LDLT, using a blood
type identical to that of the right lobe graft donated by
her 47-year-old daughter. The graft volume was 520 g
and graft volume to recipient standard liver volume ra-
tio (GV/SLV) was 51.1 %. The post-transplant graft
function was excellent, and the patient was discharged
from the hospital on postoperative day 27.
Case 2
A 46-year-old man with a history of esophageal varices
with endoscopic variceal ligation (EVL) was pointed out
of hepatitis B virus (HBV) infection and liver cirrhosis
treated with entecavir. He was admitted to the hospital
for the treatment of cholecystitis. We attempted percu-
taneous drainage with cholecystostomy to relief of his
symptom and scheduled LDLT for definitive treatment
of liver cirrhosis and cholecystitis. Open or laparo-
scopic cholecystectomy might be indicated, but he
would require LT sooner or later considering his back-
ground factors; his age of 40s with progressively deteri-
orating liver function, and his liver disease of HBV in
which reinfection could be controlled with hepatitis B
immune globulin (HBIG) and antiviral agents such as




Fig. 1 a–c Pretransplant abdominal CT imaging studies in our
case 1 before primary operation showed stones in the gallbladder
(arrow in a) and common bile duct (arrow in b). After primary
operation, abdominal CT imaging showed shrinking liver and ascites
retention (c)
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profiles before LDLT were as follows: total bilirubin,
4.3 mg/dl; albumin, 3.0 g/dl; AST, 38 U/l; INR, 1.55;
and creatinine, 0.57 mg/dl. Abdominal CT imaging
studies did not show any change without inserted cho-
lecystostomy tube and relieved inflammation in gall-
bladder (Fig. 2). His Child-Pugh score remained to be 9
(grade B) and MELD score 17, both score showing no
change before and after intervention of cholecystost-
omy unlike the patient in our case 1. LT was indicated
for him and she underwent LDLT, using a blood type
identical to that of the right lobe graft donated by his
45-year-old wife. The graft volume was 520 g and GV/
SLV was 41.8 %. The post-transplant graft function was
excellent, and the patient was discharged from the hos-
pital on postoperative day 44.
Discussion
Gallbladder disease of patients with liver cirrhosis is diffi-
cult to manage [6]. Open or laparoscopic cholecystectomy
has been reported to be performed safely in cirrhotic pa-
tients with well-compensated liver function [14], but in
our case 1 the patient with Child-Pugh B cirrhosis suffered
postoperative liver failure. Postoperative liver failure with-
out improvement with plasma exchanges is indicated for
liver transplantation; and considering the scarcity of ca-
daveric liver grafts in Japan [12], LDLT was indicated.
Endoscopic treatment would be the first-choice treatment
[4], but cirrhotic patients are at high risk of accompanying
with esophageal varices as the patient in our case 1, which
interrupt endoscopic treatment.
The best management of cirrhotic patients with
symptomatic GS might require a multidisciplinary team
of surgeons, endoscopists, and radiologists, to allow
the most efficient treatment including LT [15]. For ex-
ample in our case 2, we performed percutaneous chole-
cystostomy which controlled symptoms considering the
risks of liver failure following surgery like case 1.
Definitive treatment was mandate in this case with
multiple stones stuck in the gallbladder neck and antic-
ipated relapsing cholecystitis. We did not treat by
cholecystectomy, with preparing LDLT just in case,
because the results of emergency LDLT have been con-
sidered inferior to those of elective transplants [16].
Rather, we preceded percutaneous cholecystostomy
followed by LDLT.
Studies that stratified patients by Child-Pugh status
found greater morbidity and mortality after cholecystec-
tomy in accords with Child-Pugh class [2]. Some study
concluded to be safe for patients with liver cirrhosis of
Child-Pugh A and B to undergo laparoscopic cholecyst-
ectomy [7, 17–20]. On the other hand, a poor outcome
with cholecystectomy was observed in Child-Pugh C cir-
rhotic patients [9] and LT seems to be the only way [17].
So patients whose liver function at the boundary be-
tween Child-Pugh B and C would be challenge to treat,
and nonsurgical therapies including percutaneous chole-
cystostomy and ERC stent insertion and drainage have
frequent recurrence. So we propose that LT would be
treatment options for Child-Pugh B cirrhosis compli-
cated with GS disease; and considering recipient and
donor factors, LDLT could be indicated which treats
both liver cirrhosis and symptomatic GS disease (Fig. 3).
Conclusions
Cirrhotic patients with Child-Pugh class B and C with
symptomatic GS disease are life-threatening conditions
with significant mortality. Multidisciplinary management
in a tertiary care center considering LDLT as an option
may offer the optimal treatment.
a
b
Fig. 2 a–b. Pretransplant abdominal computed tomography CT
imaging studies in our case 2 showed gallbladder distention and
wall thickness before cholecystostomy (arrow in a), and cholecystostomy
(arrow in b) resolved these findings
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Consent
Written informed consent was obtained from the pa-
tient for publication of this case report and accompany-
ing images.
Abbreviations
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